Urteste S.A. Logo

Urteste S.A.

Develops non-invasive urine tests to detect cancers early by measuring enzyme activity.

URT | WAR

Overview

Corporate Details

ISIN(s):
PLURTST00010 (+1 more)
LEI:
259400Q4S6JIKFQHGU06
Country:
Poland
Address:
Gdańsk Starodworska 1, 80-137 Gdańsk
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Urteste S.A. is a research and development company specializing in innovative in vitro diagnostic (IVD) medical devices. The company focuses on creating a pioneering technology for the early detection of multiple types of cancer from a single, non-invasive urine sample. Its proprietary method is based on measuring the activity of specific enzymes to identify malignancies at an early stage, with the goal of substantially increasing patient survival rates. The company's development pipeline includes diagnostic tests for various cancers, such as the Panuri Test for pancreatic cancer and a test for breast cancer.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 08:18
Quarterly Report
Raport kwartalny 3Q2025
Polish 1.2 MB
2025-11-07 16:00
Share Issue/Capital Change
OPINIA ZARZĄDU uzasadniająca powody pozbawienia akcjonariuszy prawa poboru akcji
Polish 178.5 KB
2025-11-07 16:00
AGM Information
Projekty uchwał
Polish 229.9 KB
2025-11-07 16:00
Proxy Solicitation & Information Statement
Pełnomocnictwo udzielane przez osoby prawne do uczestnictwa
Polish 160.7 KB
2025-11-07 16:00
Regulatory Filings
Pełnomocnictwo udzielane przez osoby fizyczne do uczestnictwa
Polish 156.4 KB
2025-11-07 16:00
Regulatory Filings
INFORMACJE DOTYCZĄCE PRZETWARZANIA DANYCH OSOBOWYCH AKCJONARIUSZY I PEŁNOMOCNIK…
Polish 191.5 KB
2025-11-07 16:00
Declaration of Voting Results & Voting Rights Announcements
INFORMACJA o ogólnej liczbie akcji w Spółce Urteste S.A.
Polish 118.9 KB
2025-11-07 16:00
Regulatory Filings
FORMULARZ pozwalający na wykonywanie prawa głosu przez pełnomocnika
Polish 284.9 KB
2025-11-07 16:00
Pre-Annual General Meeting Information
Ogłoszenie Zarządu Urteste S.A.
Polish 217.3 KB
2025-11-07 16:00
Pre-Annual General Meeting Information
Zwołanie Nadzwyczajnego Walnego Zgromadzenia na dzień 4 grudnia 2025 roku - Con…
Polish 1.5 KB
2025-11-07 10:36
Share Issue/Capital Change
Zawarcie dwóch umów inwestycyjnych dotyczących dokapitalizowania Spółki - Conte…
Polish 2.6 KB
2025-10-31 10:46
Legal Proceedings Report
Zawarcie umowy z firmą typu CRO - rozpoczęcie wieloośrodkowego badania kliniczn…
Polish 3.2 KB
2025-10-20 17:09
Capital/Financing Update
Zawarcie umowy pożyczki - Content (PL)
Polish 1.4 KB
2025-09-29 17:38
Audit Report / Information
Opinia biegłego
Polish 366.5 KB
2025-09-29 17:38
Management Reports
Sprawozdanie z działalności Zarządu za I półrocze 2025
Polish 1.0 MB

Automate Your Workflow. Get a real-time feed of all Urteste S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Urteste S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Urteste S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapies for oncology & ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland
ACHI
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG

Talk to a Data Expert

Have a question? We'll get back to you promptly.